Latest News

The Consumer Is Back, I'm Taking A Tactical Position In Staples
The Vibecession is ending on the data. Retail sales just posted their biggest gain since the U.S.-Iran war, and I'm taking a tactical position in consumer staples.

LuxExperience: My Old Thesis Just Got Dressed
LuxExperience (LUXE) remains a Buy, offering high alpha potential and speculative risk as it targets €4 billion in sales and 7-9% adjusted EBITDA margin by FY 2030. Q4 saw all segments, even YOOX, out

PBF Energy: War Is The Unpredictable Wild Card (Rating Upgrade)
PBF Energy has surged nearly 200% YTD, with Enterprise Value now exceeding previous conflict-driven peaks. Third quarter profitability is projected to be significantly better than an already strong Q2

Kaplan Fox Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to the Lead Plaintiff Deadline on October 5, 2026
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. ("ARS" or the "Company") (

Monthly-Paid Dividends: 28 IDEAL 'Safer' September Dog Buys
Monthly pay dividend equities offer yields up to 22.05% and projected net gains of 28.23%–72.96% by 2027, per analyst targets. Top MoPay stocks like PEYUF, IPOOF, IVR, ORC, and ARR combine high yield

Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
SARASOTA, Fla., Sept. 18, 2026 /PRNewswire/ -- Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-actin

Applied Digital: A Risky Play With Material Upside
I reiterate Applied Digital Corporation with a Strong Buy and a revised of $70. APLD now boasts 1,410MW of contracted IT load across five campuses, equating to $36 billion in initial 15-year lease rev

Kaplan Fox Encourages Coastal Financial Corporation (CCB) Investors to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Coastal Financial Corporation ("Coastal" or the "Compan

Pagaya: A Round Trip To Nowhere Hides A Doubling In Profits
Pagaya Technologies retains a Buy rating, with conviction increased due to doubling of core earning power despite stock volatility. Q2 2026 results highlight 33% YoY network volume growth, 20% revenue

T. Rowe Price: Which AI Stocks Have Growth Built to Last?
Not every AI stock riding this year's rally has growth that will last, according to T. Rowe Price portfolio manager Paul Greene.

Four Corners Property Trust: A Changing REIT At A Compelling 52-Week Low Valuation
Four Corners Property Trust (FCPT) remains a Buy, supported by ongoing portfolio diversification and a solid margin of safety versus intrinsic value. FCPT's acquisitions totaled $382 million YTD at a

Ligand Pharmaceuticals: Owning It Gives You A Stake Across Biotech
Ligand Pharmaceuticals (LGND) is reassessed after a 10% loss since its last 'Buy' rating. The article focuses on LGND's future prospects, emphasizing its key royalty producing assets. LGND is highlig

$1,000 invested in Berkshire when Buffett stepped down as CEO is worth this much as he retires
Less than a year after stepping down as CEO, the legendary investor Warren Buffett decided to hand over his role as Berkshire Hathaway (NYSE: BRK.A, BRK.B) Chairman to his son, per a September 18 comp

M&T Bank Sees Broad 2026 Loan Growth as AI and Fee Businesses Gain Traction
M&T Bank NYSE: MTB Chairman and CEO René Jones said the lender is seeing broad-based loan demand in 2026, supported by what he characterized as one of the strongest operating environments of his caree

Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Friday.

WSE SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Wise Group plc (WSE) Investors of Securities Class Action Lawsuit Deadline on September 29, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Wise To Contact Him Directly To Discuss Their Options If you purchased or acquired se

Generac Plugs into Amazon for an $8B AI-Powered Deal
Training artificial intelligence requires tremendous computing power, but operating clusters of high-density processors requires something even more basic: reliable electricity. Cloud providers are co

How Atlassian Stock Shook Off 'SaaSpocalypse' AI Fears For A Big Rally
Atlassian stock has posted a 180% stock rally since the start of April.

Generac's Investment In Capacity Is Paying Off With Amazon Deal
Generac (GNRC) secures a landmark $2.4B data center backup power deal with Amazon, potentially expanding to $8B, driving shares above $207. Commercial & Industrial segment growth of 29% YoY has driven

AGNC Investment PFDs Reviewed: Ratings Revised
AGNC Investment Corp. offers a suite of preferred stocks, each with distinct risk and yield profiles for income-focused investors. Dividend coverage is robust at nearly 13x, but par value coverage has